Tri Locum Partners LP Arcturus Therapeutics Holdings Inc. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$31.23 - $42.99 $888,712 - $1.22 Million	28,457 Added 25.76%	138,927 $4.69 Million
Q4 2023 Feb 14, 2024	SELL	$17.71 - $32.97 $1.74 Million - $3.24 Million	-98,416 Reduced 47.11%	110,470 $3.48 Million
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $5.31 Million - $7.8 Million	208,886 New	208,886 $5.34 Million
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $1.04 Million - $2.32 Million	-26,722 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $924,848 - $3.3 Million	26,722 New	26,722 $1.16 Million

178

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $478M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.